Skip to main content
. 2020 Aug;23(8):990–998. doi: 10.22038/ijbms.2020.40859.9650

Table 2.

Erythrocyte insulin receptor binding constant and capacity

Groups K1
(×109 mol/L)
K2
(×107 mol/L)
Q1
(×1014 mol/L)
Q2
(×1015 mol/L)
Normal control
Diabetic control
Low dose
Medium dose
High dose
2.59±0.33*
1.17±0.45
1.25±0.46
1.69±0.39*
2.12±0.33 *
2.67±0.41*
1.31±0.49
1.18±0.52
1.62±0.37*
2.09±0.33*
1.69±0.28*
0.91±0.25
1.16±0.33
1.25±0.26*
1.27±0.31*
4.75±0.52
3.04±0.39
3.01±0.43
3.47±0.38
3.96±0.41

Data are means±SD unless otherwise indicated, (n=10).

*Compared with diabetic control group, P<0.05